a study of olaparib and cediranib in ovarian cancer
Published 7 years ago • 220 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
2:12
dr. patel on an analysis of olaparib and cediranib for ovarian cancer
-
0:53
dr. annunziata on olaparib and cediranib combination in ovarian cancer
-
2:13
dr. patel on cediranib versus olaparib in recurrent platinum-sensitive ovarian cancer
-
0:54
dr. ursula matulonis on phase iii trials examining cediranib plus olaparib in ovarian cancer
-
2:48
rationale for olaparib in advanced ovarian cancer
-
1:29
significant factors of clinical outcomes with olaparib in patients with ovarian cancer
-
1:04
olaparib maintenance therapy in ovarian cancer
-
1:11
solo3 highlights toxicities with olaparib in ovarian cancer
-
1:38
dr. liu on cediranib/olaparib in recurrent ovarian cancer
-
1:25
olaparib in ovarian cancer
-
0:50
challenges with targeted therapies in ovarian cancer
-
2:27
the paola-1 study: olaparib and bevacizumab for ovarian cancer
-
39:03
the therapeutic potential of novel parp inhibitors in the clinic for epithelial ovarian cancer
-
4:19
cediranib plus olaparib increases progression-free survival in recurrent ovarian cancer
-
4:52
cediranib plus olaparib significantly increases pfs in recurrent ovarian cancer
-
2:35
clinical use of niraparib in ovarian cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
3:58
solo-1: practice changing data on olaparib for ovarian cancer
-
11:22
olaparib in ovarian cancer